Hydrolytic stability of nucleoside phosphotriesters derived from bis(hydroxymethyl)-1,3-dicarbonyl compounds and their congeners: towards a novel pro-drug strategy for antisense oligonucleotides

Citation
M. Ora et al., Hydrolytic stability of nucleoside phosphotriesters derived from bis(hydroxymethyl)-1,3-dicarbonyl compounds and their congeners: towards a novel pro-drug strategy for antisense oligonucleotides, J CHEM S P2, (6), 2001, pp. 881-885
Citations number
14
Categorie Soggetti
Physical Chemistry/Chemical Physics
Journal title
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
ISSN journal
1472779X → ACNP
Issue
6
Year of publication
2001
Pages
881 - 885
Database
ISI
SICI code
1472-779X(2001):6<881:HSONPD>2.0.ZU;2-J
Abstract
Four different nucleoside phosphodiester protecting groups derived from bis (hydroxymethyl)-1,3-dicarbonyl compounds and their congeners have been prep ared and introduced to 5'-O-pivaloylthymidine 3'-(2-methoxyethyl)phosphate and its monothioate analogs. Nucleoside phosphotriesters having either 2,2- bis(ethoxycarbonyl)-3-(4,4'-dimethoxytrityloxy)propyl (1a), 2-cyano-2-metho xycarbonyl-3-(4,4'-dimethoxytrityloxy)propyl (1b), 2,2-bis(cyano)-3-(4,4'-d imethoxytrityloxy)propyl (1c) or 2-acetyl-2-benzoyl-3-(4,4'-dimethoxytrityl oxy)propyl (1d) protecting group have been prepared. Additionally were synt hesized the O- and S-esterified phosphoromonothioate analogs of 1b. After r emoval of the dimethoxytrityl groupunder acidic conditions, each of the det ritylated protecting groups is readily cleaved from the phosphate/thiophosp hate moiety by a reaction suggested to involve a base-catalyzed retro-aldol condensation and following elimination of the phosphodiester from the form ed carbanion intermediate. The kinetics of the hydroxide ion-catalyzed clea vage have been studied by HPLC over a pH range 2-7. The half-lives of the c leavage at pH 7 and 25 degreesC vary from 0.3 s (for 1c) to 5500 s (for 1a) . The results confirm that these protecting groups have promising chemical properties for use in the development of antisense oligonucleotide pro-drug strategies.